Breadcrumb
Documents and Media
Introducing the Treatment Hierarchy Question in Network Meta-Analysis
Introducing the Treatment Hierarchy Question in Network Meta-Analysis
Version 1.0 Approved
- Document Type
- EXTERNAL_DOCUMENT
- Extension
- png
- Size
- 139 KB
- Modified
- 21/10/22 13:28 by mir mir
- Created
- 21/10/22 13:28 by mir mir
- Location
- PUBLIC
- Ratings
-
-
Version 1.0By mir mir, on 21/10/22 13:28No Change Log
Abstract
Comparative effectiveness research using network meta-analysis can present a hierarchy of competing treatments, from the most to the least preferable option. However, in published reviews, the research question associated with the hierarchy of multiple interventions is typically not clearly defined. Here we introduce the novel notion of a treatment hierarchy question that describes the criterion for choosing a specific treatment over one or more competing alternatives. For example, stakeholders might ask which treatment is most likely to improve mean survival by at least 2 years, or which treatment is associated with the longest mean survival. We discuss the most commonly used ranking metrics (quantities that compare the estimated treatment-specific effects), how the ranking metrics produce a treatment hierarchy, and the type of treatment hierarchy question that each ranking metric can answer. We show that the ranking metrics encompass the uncertainty in the estimation of the treatment effects in different ways, which results in different treatment hierarchies. When using network meta-analyses that aim to rank treatments, investigators should state the treatment hierarchy question they aim to address and employ the appropriate ranking metric to answer it. Following this new proposal will avoid some controversies that have arisen in comparative effectiveness research.

The COMPAR-EU project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 754936.
Please consider, this is the Beta version of the COMPAR-EU platform. The platform will be expanded and improved in the next months.